Fosså SD - Search Results

1

Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC Genito-urinary Tract Cancer Cooperative Group.

van Oosterom AT, Fosså SD, Mulder JH, Calciati A, de Pauw M, Sylvester R. van Oosterom AT, et al. Among authors: fossa sd. Eur J Cancer Clin Oncol. 1985 Sep;21(9):1013-4. doi: 10.1016/0277-5379(85)90284-6. Eur J Cancer Clin Oncol. 1985. PMID: 4065174

2

Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group.

Fosså SD, Droz JP, Pavone-Macaluso MM, Debruyne FJ, Vermeylen K, Sylvester R. Fosså SD, et al. Eur J Cancer. 1992;28A(4-5):878-80. doi: 10.1016/0959-8049(92)90139-s. Eur J Cancer. 1992. PMID: 1524914 Clinical Trial.

3

Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group.

Jones WG, Fosså SD, Verbaeys AC, Droz JP, Klijn JG, Boven E, de Pauw M, Sylvester R. Jones WG, et al. Among authors: fossa sd. Eur J Cancer. 1990;26(5):646. doi: 10.1016/0277-5379(90)90099-f. Eur J Cancer. 1990. PMID: 2144757 No abstract available.

4

Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group.

Fosså SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth KH, de Pauw M. Fosså SD, et al. Eur J Cancer. 1990;26(11-12):1133-6. doi: 10.1016/0277-5379(90)90269-y. Eur J Cancer. 1990. PMID: 2149995 Clinical Trial.

5

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.

Fosså SD, Splinter T, Roozendaal KJ, Veenhof KH, Pavone-Macaluso M, Calciati A, de Pauw M, Sylvester R. Fosså SD, et al. Eur J Cancer Clin Oncol. 1989 Feb;25(2):389-90. doi: 10.1016/0277-5379(89)90035-7. Eur J Cancer Clin Oncol. 1989. PMID: 2702991 No abstract available.

6

Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.

van Oosterom AT, Stoter G, Bono AV, Splinter TA, Fossa SD, Verbaeys AJ, de Mulder PH, de Pauw M, Sylvester R. van Oosterom AT, et al. Among authors: fossa sd. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1249-50. doi: 10.1016/0277-5379(89)90422-7. Eur J Cancer Clin Oncol. 1989. PMID: 2767112 No abstract available.

7

European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.

Jones WG, Fosså SD, Bono AV, Klijn JG, De Pauw M, Sylvester R. Jones WG, et al. Among authors: fossa sd. Cancer Treat Rep. 1987 Dec;71(12):1317-8. Cancer Treat Rep. 1987. PMID: 3480046 No abstract available.

8

Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder.

Stoter G, Splinter TA, Child JA, Fosså SD, Denis L, van Oosterom AT, de Pauw M, Sylvester R. Stoter G, et al. Among authors: fossa sd. J Urol. 1987 Apr;137(4):663-7. doi: 10.1016/s0022-5347(17)44168-1. J Urol. 1987. PMID: 3560318

9

4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.

van Oosterom AT, Bono AV, Kaye SB, Splinter TA, Calciati A, Fosså SD, de Pauw M, Sylvester R. van Oosterom AT, et al. Among authors: fossa sd. Eur J Cancer Clin Oncol. 1986 Dec;22(12):1531-2. doi: 10.1016/0277-5379(86)90091-x. Eur J Cancer Clin Oncol. 1986. PMID: 3595678 No abstract available.

10

Radiotherapy of T4 bladder carcinoma.

Fosså SD, Kaalhus O, Sauer T, Hager B, Lund G. Fosså SD, et al. Radiother Oncol. 1984 Mar;1(4):291-8. doi: 10.1016/s0167-8140(84)80016-x. Radiother Oncol. 1984. PMID: 6209751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

937 results

Search Page

Filters